Eli Lilly’s New Weight-Loss Drug Mimics Bariatric Surgery Results

The experimental drug boosts hormone levels that affect metabolism and hunger to help people lose as much as 50 pounds.

Screen Shot 2022 04 18 At 2 50 22 Pm
Getty Images

Bariatric surgery, also known as gastric bypass, is the process of changing the digestive system to help people lose weight. It’s somewhat of a last-resort when diet and exercise have failed, and a patient is experiencing serious health problems due to their weight. The process is painful and invasive, but produces dramatic results. However, according to a recent Gizmodo article, Eli Lilly has a new drug that produces similar weight-loss results without all the trouble.

The drug is called tirzepatide, and it has helped people lose up to 50 pounds, or 22% of their total body weight. Though the findings are preliminary, they suggest the experimental drug could become an affordable alternative to surgery. It works by boosting levels of the GLP-1 and GIP hormones, which are vital in regulating metabolism and hunger. A similar drug, Novo Nordisk’s Wegovy, received FDA approval last June. However, it costs about $1400 a month, and isn’t covered by basic Medicare plans. The introduction of a second drug will introduce competition to the market and likely drive prices down.

More in Home